Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novartis
Manufactures and markets health care and nutritional products

Novartis AG develops, manufactures, and markets healthcare products.

It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, and Corporate Activities.

The Pharmaceuticals segment provides patent-protected prescription medicines.

The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products.

The Sandoz segment supplies generic pharmaceuticals.

The Corporate Activities segment includes other items of income and expense which are not attributable to specific segments such as certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations, and sponsorships.

The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Number of employees : 118 393 persons.
Sales per Businesses
20152016Delta
CHF (in Million)%CHF (in Million)%
Innovative Medicines29,34561.6%32,09567.1% +9.37%
Alcon9,45719.9%5,72912% -39.43%
Sandoz8,82618.5%9,99820.9% +13.28%
Sales per Regions
20152016Delta
CHF (in Million)%CHF (in Million)%
Other19,84641.7%19,81041.4% -0.18%
United States17,42636.6%16,87135.3% -3.18%
Germany3,1446.6%3,5827.5% +13.92%
Japan3,0496.4%3,2206.7% +5.62%
France2,1874.6%2,3564.9% +7.71%
United Kingdom1,2312.6%1,1652.4% -5.35%
Switzerland746.031.6%818.081.7% +9.66%
Managers
NameAgeSinceTitle
Joseph Jimenez582007Chief Executive Officer
Jörg Reinhardt602013Independent Non-Executive Chairman
Harry Kirsch522003Chief Financial Officer
Vasant Narasimhan, MD412005Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar, PhD642003Independent Non-Executive Director
Pierre Landolt, PhD701996Independent Non-Executive Director
Andreas von Planta, PhD622006Independent Non-Executive Director
Ann Marie Fudge, MBA662008Independent Non-Executive Director
Enrico Cipro Vanni PhD, MBA652011Vice Chairman
Dimitri Azar MD, EMBA572012Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,580,395,579 2,275,448,244 88.2% 253,055,807 9.8% 88.2%
Shareholders
NameEquities%
Novartis AG 253,055,807 9.67%
Sandoz Family Foundation 89,321,902 3.41%
Novartis Foundation For Employee Participation 68,304,984 2.61%
The Vanguard Group, Inc. 60,206,315 2.30%
Norges Bank Investment Management 53,075,518 2.03%
UBS AG (Investment Management) 39,411,588 1.51%
Capital Research & Management Co. (Global Investors) 38,727,894 1.48%
Wellington Management Co. LLP 28,806,805 1.10%
BlackRock Fund Advisors 27,716,928 1.06%
Credit Suisse Asset Management (Schweiz) AG 21,545,992 0.82%
Holdings
NameEquities%Valuation
Roche Holding (RO) 53,332,86333.3%12,402,244,760 USD
Novartis India Limited (NOIN) 20,656,04273.4%202,458,543 USD
Mereo BioPharma Group PLC (MPH) 13,767,84119.5%60,790,938 USD
Momenta Pharmaceuticals, Inc. (MNTA) 3,315,3664.35%46,746,661 USD
GenSight Biologics (SIGHT) 3,521,77414.7%21,128,848 USD
XOMA Corp (XOMA) 539,1316.62%13,095,492 USD
Arrowhead Pharmaceuticals Inc (ARWR) 3,321,3834.44%12,089,834 USD
Oxford BioMedica plc (OXB) 70,778,0002.28%8,411,965 USD
BioLineRX Ltd. 5,000,0004.80%5,174,000 USD
Symetis (SYMS) 814,33914.2%8 USD
Markets and indexes
- SIX Swiss Exchange
- Main Standard
- FTSE Eurotop 100 / Low Carbon 100 Europe, SMI, Stoxx Europe 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  NOVN.S
- Datastream Code :  S:NOVS
Company contact information
Novartis
35 Lichtstrasse
CH-4002 Basel, Basel-Stadt
Switzerland

Phone : +41 61 324 79 44
Fax : +41 61 324 8001
Internet : http://www.novartis.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
NOVARTIS13.09%221 731
JOHNSON & JOHNSON22.95%382 722
PFIZER12.25%221 738
ROCHE HOLDING LTD.3.91%212 270
MERCK AND COMPANY-4.86%153 386
AMGEN21.32%128 515
SANOFI-4.07%109 152
BAYER6.02%103 473
BRISTOL-MYERS SQUIBB COMPANY8.61%102 146
NOVO NORDISK A/S29.37%102 077
ABBOTT LABORATORIES42.49%96 603
ELI LILLY AND COMPANY19.50%95 289
CELGENE CORPORATION-6.52%86 140
GLAXOSMITHKLINE-17.09%84 827
ASTRAZENECA9.99%82 988
ALLERGAN PLC-19.41%57 098
SHIRE-21.33%45 962
TAKEDA PHARMACEUTICAL CO LTD28.65%43 682
CHUGAI PHARMACEUTICAL CO LTD74.07%29 167
JIANGSU HENGRUI MEDICINE CO LTD53.05%28 792
ASTELLAS PHARMA INC-11.93%26 292
Connections : Novartis
Lenz & Staehelin AG
National Academy of Medicine of United States
Clinique Générale Beaulieu SA
International Federation of Pharmaceutical Manufacturers A
Verb Surgical, Inc.
T-Mobile USA, Inc.
Socotab Frana SA
The Genomics Institute of the Novartis Research Foundation
Jan Autos Holding SA
Novartis, Inc.
European Federation of Pharmaceutical Industries & Assns
Harvard Business School
Raymond Weil SA
American Accounting Association
AP Møller Finance SA
Institute of Management Accountants, Inc.
Institute of Medicine
Landolt & Cie SA
Chicago Ophthalmological Society
Axial Participações e Projetos Ltda.
University of Illinois
Swiss National Insurance Co.
Novartis Institutes for Biomedical Research, Inc.
Simmons College (Massachusetts)
HSBC Private Banking Holdings (Suisse) SA
The Brookings Institution
Generale Beaulieu Holding SA
Novartis Pharmaceuticals
Burberry Suisse SA
Eclosion2 SA
SIX Swiss Exchange AG
Mocó Agropecuária Ltda.
Instituto Fazenda Tamanduá
Instituto Estrela de Fomento ao Microcrédito
The Rockefeller Foundation
Banco AXIAL SA
Sandoz Family Foundation
US Department of State (District of columbia)
Emasan AG
Denzler & Partners
Vaucher Manufacture Fleurier SA
Banque Privée BCP (Suisse) SA
Amazentis SA
The Association for Research in Vision & Ophthalmology
Parmigiani Fleurier SA
Tear Film & Ocular Surface Society
Montreux Jazz Festival Foundation
American Ophthalmological Society
Syngenta Foundation For Sustainable Agriculture
Chicago Medical Society Foundation
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem